Nusrat Rabbee

923 total citations
17 papers, 648 citations indexed

About

Nusrat Rabbee is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Nusrat Rabbee has authored 17 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Nusrat Rabbee's work include Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Nusrat Rabbee is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Nusrat Rabbee collaborates with scholars based in United States, Australia and Italy. Nusrat Rabbee's co-authors include Terence P. Speed, Ed Tom, Moraima Pagan, Hui Wang, Giulia C. Kennedy, C. Ted Rigl, Darya Chudova, Virginia A. LiVolsi, Giovanni Fellegara and Jessica Reynolds and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Nusrat Rabbee

14 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nusrat Rabbee United States 9 241 207 197 83 59 17 648
Márcia Silveira Graudenz Brazil 16 120 0.5× 198 1.0× 113 0.6× 94 1.1× 47 0.8× 52 699
Juanita García-Aragón Australia 9 190 0.8× 216 1.0× 426 2.2× 76 0.9× 12 0.2× 11 662
Kathleen Mathers United Kingdom 10 119 0.5× 245 1.2× 152 0.8× 63 0.8× 36 0.6× 10 574
Soo‐Mi Park United Kingdom 15 258 1.1× 464 2.2× 147 0.7× 74 0.9× 8 0.1× 39 794
G. Scarlato Italy 13 94 0.4× 292 1.4× 72 0.4× 69 0.8× 95 1.6× 31 888
Eva‐Pia Reich United States 9 277 1.1× 109 0.5× 121 0.6× 190 2.3× 31 0.5× 11 609
Marina Ciullo Italy 16 220 0.9× 291 1.4× 36 0.2× 33 0.4× 19 0.3× 34 738
Aleš Neuwirth Czechia 18 82 0.3× 121 0.6× 51 0.3× 51 0.6× 126 2.1× 29 563
Makiko Meguro‐Horike Japan 14 268 1.1× 477 2.3× 111 0.6× 57 0.7× 6 0.1× 35 829

Countries citing papers authored by Nusrat Rabbee

Since Specialization
Citations

This map shows the geographic impact of Nusrat Rabbee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nusrat Rabbee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nusrat Rabbee more than expected).

Fields of papers citing papers by Nusrat Rabbee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nusrat Rabbee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nusrat Rabbee. The network helps show where Nusrat Rabbee may publish in the future.

Co-authorship network of co-authors of Nusrat Rabbee

This figure shows the co-authorship network connecting the top 25 collaborators of Nusrat Rabbee. A scholar is included among the top collaborators of Nusrat Rabbee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nusrat Rabbee. Nusrat Rabbee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Zhuang, Yan, Pritam Mukherjee, Boah Kim, et al.. (2025). MRISegmenter: A Fully Accurate and Robust Automated Multiorgan and Structure Segmentation Tool for T1-weighted Abdominal MRI. Radiology. 315(1). e241979–e241979. 2 indexed citations
3.
Mannes, Andrew J., John D. Heiss, Ann Berger, et al.. (2025). Treatment of Intractable Cancer Pain with Resiniferatoxin — An Interim Study. NEJM Evidence. 4(6). EVIDoa2400423–EVIDoa2400423. 1 indexed citations
4.
Moline, Margaret, Stephen Thein, Mohammad Bsharat, et al.. (2021). Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial. The Journal of Prevention of Alzheimer s Disease. 8(1). 7–18. 31 indexed citations
5.
Rabbee, Nusrat. (2020). Biomarker Analysis in Clinical Trials with R. 1 indexed citations
6.
Holl, Jane L., et al.. (2020). (1) A Randomized Trial of the Acceptability of a Daily Multi-Allergen Food Supplement for Infants. Journal of Allergy and Clinical Immunology. 145(2). AB50–AB50.
7.
Chudova, Darya, Jonathan I. Wilde, Eric T. Wang, et al.. (2010). Molecular Classification of Thyroid Nodules Using High-Dimensionality Genomic Data. The Journal of Clinical Endocrinology & Metabolism. 95(12). 5296–5304. 192 indexed citations
8.
Speca, David J., Amir M. Ashique, M. Scott Bowers, et al.. (2010). Conserved Role of unc-79 in Ethanol Responses in Lightweight Mutant Mice. PLoS Genetics. 6(8). e1001057–e1001057. 39 indexed citations
10.
Beeram, M., Ian E. Krop, Shanu Modi, et al.. (2007). A phase I study of trastuzumab-MCC-DM1 (T-DM1), a first-in-class HER2 antibody-drug conjugate (ADC), in patients (pts) with HER2+ metastatic breast cancer (BC). Journal of Clinical Oncology. 25(18_suppl). 1042–1042. 26 indexed citations
11.
Krop, IE, M. Beeram, Shanu Modi, et al.. (2007). 2118 POSTER A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer. European Journal of Cancer Supplements. 5(4). 219–219. 4 indexed citations
12.
Amler, Lukas C., Michael S. Gordon, Andreas C. Strauß, et al.. (2006). Identification of predictive markers of clinical activity from a phase II trial of single agent pertuzumab (rhuMab 2C4), a HER dimerization inhibitor, in advanced ovarian cancer (OC). Journal of Clinical Oncology. 24(18_suppl). 3001–3001. 1 indexed citations
13.
Speca, David J., et al.. (2005). A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in mice. Genes Brain & Behavior. 5(1). 19–28. 18 indexed citations
14.
Rabbee, Nusrat & Terence P. Speed. (2005). A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics. 22(1). 7–12. 266 indexed citations
15.
Rabbee, Nusrat & Rebecca A. Betensky. (2004). Power calculations for familial aggregation studies. Genetic Epidemiology. 26(4). 316–327. 4 indexed citations
16.
Rabbee, Nusrat, David J. Speca, Nicola J. Armstrong, & Terence P. Speed. (2004). Power calculations for selective genotyping in QTL mapping in backcross mice. Genetics Research. 84(2). 103–108. 9 indexed citations
17.
Rabbee, Nusrat, Brent A. Coull, Cyrus R. Mehta, Nikunj K. Patel, & Pralay Senchaudhuri. (2003). Power and sample size for ordered categorical data. Statistical Methods in Medical Research. 12(1). 73–84. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026